| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/02/2008 | EP1904457A2 Compositions and methods for inhibition of the jak pathway |
| 04/02/2008 | EP1904446A2 Azabicyclo derivatives as muscarinic receptor antagonists |
| 04/02/2008 | EP1232147B1 Triazoles as farnesyl transferase inhibitors |
| 04/02/2008 | CN101155800A Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 04/02/2008 | CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 04/02/2008 | CN101155783A Pyrazoles |
| 04/02/2008 | CN101155780A Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 04/02/2008 | CN101153036A Organic light-emitting compound and organic light-emitting element comprising the same |
| 04/02/2008 | CN101153022A Isoquinolinium compound, producing method and application of its salt |
| 04/02/2008 | CN101153021A Isoquinolinium compound, producing method and application of its salt |
| 04/02/2008 | CN100378114C Propiconazol metal complex, preparation method and use thereof |
| 04/02/2008 | CN100378092C Biphenyl derivatives |
| 04/02/2008 | CN100378087C Novel ascorbic acid compounds, methods of synthesis and application use thereof |
| 04/02/2008 | CN100378081C Process for the manufacture of organic compounds |
| 04/02/2008 | CN100378076C Pyridine carboxamide derivatives and their use as pesticides |
| 04/02/2008 | CN100378075C Aniline derivative using as phosphodiesterase 4 inhibitor |
| 04/01/2008 | US7351829 Compounds on the basis of 2- and 4-chromenylidene-merocyanines respectively, and their use |
| 04/01/2008 | US7351827 Substituted oxetanes, method of making, and method of use thereof |
| 04/01/2008 | US7351807 Cyanine-sulfenates for dual phototherapy |
| 04/01/2008 | US7351738 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 04/01/2008 | US7351735 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias |
| 04/01/2008 | US7351720 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula |
| 04/01/2008 | US7351712 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one |
| 04/01/2008 | CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 04/01/2008 | CA2272361C Polyether-modified polyisocyanate mixtures having improved dispersibility in water |
| 04/01/2008 | CA2145661C Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 03/27/2008 | WO2008036247A1 Renin inhibitors |
| 03/27/2008 | WO2008035726A1 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
| 03/27/2008 | WO2008034891A2 Novel genes related to glutaminyl cyclase |
| 03/27/2008 | WO2008034600A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 03/27/2008 | WO2008010934A3 Triazolyl phenyl benzenesulfonamides |
| 03/27/2008 | WO2008009405A3 Novel pyridazine derivatives |
| 03/27/2008 | WO2008002671A3 Metalloprotease inhibitors |
| 03/27/2008 | WO2007136573A3 Antidiabetic bicyclic compounds |
| 03/27/2008 | WO2007109334B1 Sip receptor modulating compounds and use thereof |
| 03/27/2008 | WO2007094513A3 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| 03/27/2008 | WO2006125621A8 Substituted piperidines as renin inhibitors |
| 03/27/2008 | US20080076932 A process for the preparation of phenyltetrazole compounds |
| 03/27/2008 | US20080076817 Neurotrophic N-glyoxyl-prolyl ester compounds e.g. 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; non-immunosuppressive; side effect reduction; neurodegenerative diseases |
| 03/27/2008 | US20080076815 Sulfonamide or sulfonimide functional indazole or indole compounds such as N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydryoxyethyl]phenyl]methanesulfonamide; diabetes, obesity, hyperlipidemia and urinary incontinence |
| 03/27/2008 | US20080076813 Benzene, Pyridine, and Pyridazine Derivatives |
| 03/27/2008 | US20080076800 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/27/2008 | US20080076782 Sodium channel blockers |
| 03/27/2008 | US20080076778 PARP (poly-ADP ribose polymerase); drug screening; computer networks |
| 03/27/2008 | US20080076759 Therapeutic Heterocyclic Compounds 507 |
| 03/27/2008 | US20080076752 substituted structure of 3-amino-2-(2,5-difluorophenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one; 6-amino-7-phenyl-1,4-thiazepan-5-one; -amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one for treating neurological disorders such as Alzheimer's; inhibit the production of amyloid beta protein |
| 03/27/2008 | CA2663635A1 Novel genes related to glutaminyl cyclase |
| 03/27/2008 | CA2663263A1 Renin inhibitors |
| 03/27/2008 | CA2662838A1 Oxindole derivatives |
| 03/27/2008 | CA2662359A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 03/27/2008 | CA2603705A1 A process for the preparation of phenyltetrazole compounds |
| 03/26/2008 | EP1903038A1 N-(1-hetaryl-piperidin-4-yl)-(het)arylamide as EP2 receptor modulators |
| 03/26/2008 | EP1902717A2 Vasopressin antagonist and oxytocin antagonist |
| 03/26/2008 | EP1902052A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 03/26/2008 | EP1902046A1 Piperidine derivatives useful as histamine h3 antagonists |
| 03/26/2008 | EP1902044A1 5-htx modulators |
| 03/26/2008 | EP1902036A2 Process for the preparation of rosuvastatin |
| 03/26/2008 | EP1902028A2 Histamine h3 receptor antagonists |
| 03/26/2008 | EP1902025A1 Kinase inhibitors |
| 03/26/2008 | EP1901752A2 Compositions and methods for viral inhibition |
| 03/26/2008 | EP1901743A1 Quinoline derivatives as antibacterial agents |
| 03/26/2008 | EP1716133B1 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors |
| 03/26/2008 | EP1696924B1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 03/26/2008 | EP1613594B1 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 03/26/2008 | EP1562934B1 Amino-heterocycles as vr-1 antagonists for treating pain |
| 03/26/2008 | EP1556362B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
| 03/26/2008 | EP1455790B1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 03/26/2008 | CN101151258A Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 03/26/2008 | CN101151249A Cyclopentapyridine and tetrahydroquinoline derivatives |
| 03/26/2008 | CN101151247A 3,4,5-substituted piperidines as renin inhibitors |
| 03/26/2008 | CN101151246A 1-benzylindole-2-carboxamide derivatives |
| 03/26/2008 | CN101148446A L-configuration hexa-member heterocycle glycosyl pyrimidine nucleoside derivatives and preparation method thereof |
| 03/26/2008 | CN100377006C Hydrazone-based charge transport materials |
| 03/26/2008 | CN100377005C Organophotoreceptor with charge transport compound with an azine group |
| 03/26/2008 | CN100376570C Dioxolane analogs for improved inter-cellular delivery |
| 03/26/2008 | CN100376569C Inhibitors of farnesyl protein transferase |
| 03/26/2008 | CN100376564C Substituted heterocyclic benzoeycloalkenes and the use thereof as substances having analgesic effect |
| 03/26/2008 | CN100376557C Quinoline derivatives as ligands for the neuropeptide y receptor |
| 03/26/2008 | CN100376555C Process for preparing diindolylmethane derivatives |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348357 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 03/25/2008 | US7348355 Treating obesity with the Microsomal triglyceride transfer protein inhibitor (S) N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide and another lipid lowering agent such as a statin or fibrate |
| 03/25/2008 | US7348353 Acetylene derivatives having mGluR 5 antagonistic activity |
| 03/25/2008 | US7348346 Use as antidiabetic agents, treating hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis; (3S, 5S)-4-([5-(Thiazolidine-3-carbonyl)-pyrrolidin-3-ylmethyl]-sulfamoyl)-benzoic acid for example |
| 03/25/2008 | US7348343 N-(N-heteroaryl)1-pyridyl- or -pyrimidyl-hydropyridine-4-carboxamides; e.g., 3'-Chloro-3,6-dihydro-2H-[1,2']bipyridinyl-4-carboxylic acid (6-trifluoromethyl-pyridin-3-yl)-amide and 1-pyrimidin-2-yl-1,2,3,6-tetrahydro-pyridine-4-carboxylic acid (6-trifluoromethyl-pyridin-3-yl)-amide |
| 03/25/2008 | US7348340 "caused" by the stimulation of nociceptive receptors and transmitted over intact neural pathways; 2-(4-Chlorophenyl)-quinoline-4,6-diamine; acute, persistent and neuropathic pain |
| 03/25/2008 | US7348338 PPAR active compounds |
| 03/25/2008 | US7348335 Compositions useful as inhibitors of JAK and other protein kinases |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348326 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 03/25/2008 | US7348324 Cyclic amine compounds as CCR5 antagonists |
| 03/25/2008 | US7348307 Treating Non-Hodgkins lymphoma by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 03/25/2008 | CA2371178C Prucalopride oral solution |
| 03/25/2008 | CA2268394C New heterocyclylmethyl-substituted pyrazol derivates |
| 03/25/2008 | CA2174707C Chromone derivatives as nk1 and substance p antagonists |
| 03/25/2008 | CA2173493C Fused pyridazine compounds |